Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 Months to 18

Using magnesium sulfate to reduce opioid use in children having laparoscopic appendectomy

Official title: The Effect of Intravenous Magnesium Infusion on the Opioid Consumption, the Circulatory, Metabolic and Hormonal Response to Intubation and Surgical Trauma During Anaesthesia for Laparoscopy in Children. Randomized Clinical Trial.

Run by Medical University of Warsaw · NCT06563349 · Data updated 2026-11-12

This study tests if giving magnesium sulfate through an IV can help reduce the amount of opioids kids need during laparoscopic appendectomy surgery.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Months to 18 Years
SexAll
Enrollment188 (estimated)
SponsorMedical University of Warsaw
Academic / other
Locations1 site (Warsaw)
StatusRecruiting
StartedSeptember 9, 2024
Main results expectedSeptember 1, 2027
Study endsNovember 1, 2027
Registry record updatedAugust 20, 2026
Trial IDNCT06563349 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children classified as ASA physical status class 1E, 2E, or 3E who are scheduled for laparoscopic appendectomy.

Probably not a fit

Patients with allergies to magnesium sulfate, renal failure, or other specified medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of intravenous magnesium sulfate infusion as a co-analgesic in children undergoing laparoscopic appendectomy. It aims to assess its impact on opioid consumption and the physiological responses to anesthesia and surgical trauma. The study follows a multimodal approach to anesthesia, combining different methods and medications to minimize opioid use. The primary outcome is the measurement of opioid consumption during the procedure, while secondary outcomes include various intraoperative responses.

Why it matters

Potential benefit: If successful, this approach could significantly reduce opioid consumption in pediatric patients, leading to improved pain management and fewer side effects.

How similar studies have gone: While magnesium sulfate has shown promise in reducing analgesic consumption in some pediatric populations, high-quality randomized controlled trials specifically for laparoscopic appendectomy in children are still lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ASA (American Society of Anesthesiologists) physical status class 1E, 2E, 3E (E - emergency)
* Patients undergoing laparoscopic appendectomy

Exclusion Criteria:

* Allergy to the magnesium sulfate or the excipient
* Hypermagnesemia
* Renal failure (GFR \<30 ml/min)
* Myasthenia gravis
* Preoperative atrioventricular block
* Hypotension
* The use of digitalis glycosides
* The use of oral anticoagulants
* ASA physical status class 4E or higher
* Chronic treatment with analgesics
* Legal guardians or patient refusal

Where it's running

  • Uniwersity Clinic Centre of Medical Uniwersity of Warsaw
    Warsaw, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.